98%
921
2 minutes
20
Background: Hispanics are the largest and fastest growing ethnic minority population in the United States yet are poorly represented in cardiovascular outcomes studies. UC San Diego Health is a primary percutaneous coronary intervention (PCI) center for a diverse group of patients given its proximity to Mexico and underserved rural southeast Imperial County.
Objectives: The purpose of this study was to study the association between Hispanic ethnicity, geography, insurance status, and PCI outcomes.
Methods: The UC San Diego Health internal National Cardiovascular Data Registry CathPCI Registry was used to obtain data on patients who underwent PCI from January 2007 to September 2022. Complications and all-cause mortality within 1-year post-PCI were assessed.
Results: A total of 8,295 patients (age 66 years [IQR: 58-75 years], 72% male, 33% Hispanic ethnicity, and 30% from Imperial County) were included. Hispanics and patients from Imperial County irrespective of race or ethnicity had higher body mass index and were more likely to have diabetes, hypertension, hyperlipidemia, end-stage renal disease, and peripheral vascular disease. There was no difference in mortality rates between Hispanic and non-Hispanic Whites in the entire population. However, within Imperial County, Hispanics had significantly higher 30-day (1.4% vs 0.3% P = 0.02), 6-month (2.2% vs 0.8% P = 0.01), and 1-year (2.9% vs 0.9% P = 0.004) mortality rates compared to non-Hispanic Whites. Patients in Imperial County had lower 30-day (1.2% vs 1.9% P = 0.01), 6-month (1.9% vs 3.3% P < 0.001), and 1-year (2.4% vs 5% P < 0.001) mortality rates compared to patients outside of Imperial County. There was no difference in all-cause mortality rates by insurance status in non-Hispanic Whites. Uninsured Hispanic patients had a higher 30-day mortality rate compared to Hispanic patients who had Medicare/Medicaid or private insurance (4.5% vs 2.0% vs 1.0% P = 0.005). Within Imperial County, uninsured Hispanic patients had markedly higher 30-day mortality rate compared to Hispanic patients who had Medicare/Medicaid or private insurance (10.4% vs 1.6% vs 0.3% P < 0.001).
Conclusions: In socioeconomically disadvantaged areas, Hispanic patients had worse outcomes compared to non-Hispanic Whites compounded by uninsured status. There are complex demographic disparities in PCI outcomes for Hispanic patients and those residing in border zones which need to be recognized and mitigated.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059334 | PMC |
http://dx.doi.org/10.1016/j.jacadv.2025.101723 | DOI Listing |
Arch Dis Child
September 2025
Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Hepatitis B virus (HBV) is a potentially chronic infection that can be transmitted from mother to child with the risk of developing cirrhosis, liver failure and hepatocellular carcinoma. There is a safe and effective vaccine to prevent vertical transmission that is recommended to be given as soon as possible after birth and within 24 hours.When a woman with HBV refuses the birth dose of HBV vaccine for her baby, infectious diseases and safeguarding teams are asked to provide urgent opinions on whether this crosses the threshold for triggering child protection mechanisms.
View Article and Find Full Text PDFLancet Respir Med
August 2025
Division of Respiratory Medicine and Gastroenterology, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK. Electronic address:
Background: Previous studies have suggested that daily symptoms are a marker of bronchiectasis disease activity and could therefore identify patients at increased risk of exacerbation. However, international bronchiectasis guidelines recommend long-term macrolide treatment only in patients with three or more exacerbations per year. We aimed to investigate if symptoms independently predict future exacerbations and therefore identify additional responders to long-term macrolide treatment.
View Article and Find Full Text PDFHeart Fail Rev
August 2025
University of Utah Health Sciences Center, Salt Lake City, UT, USA.
Although congestion is present in the large majority of patients hospitalized with acute heart failure (AHF), the pharmacological options to treat it remain poorly studied, with heterogeneity in real-world practices and outcomes. The best available evidence supports that patients with AHF and congestion should be initially treated with i.v.
View Article and Find Full Text PDFBMJ Open
August 2025
Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK
Introduction: Pancreatic ductal adenocarcinoma (PDAC) continues to have extremely poor patient outcomes, unlike other cancer types which have seen significant improvements in their treatments and survival. A major contributing factor is that PDAC is often detected at an advanced, incurable stage. In the UK, nearly half of patients have stage 4 disease at the time of diagnosis, which has a profound effect on treatment options and, ultimately, survival.
View Article and Find Full Text PDFInt J Cancer
August 2025
Molecular Epidemiology Research Group, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Human fatty acid binding protein-4 (FABP-4), a protein elevated in obesity that promotes colon cancer cell invasiveness and metastasis, may be associated with higher mortality in individuals with colorectal cancer (CRC) and may serve as a mediator of the obesity-mortality association in these individuals. We used a causal diagram to inform covariate selection and applied Cox proportional hazards models to estimate hazard ratios (HRs) for CRC-specific, non-CRC-specific, and all-cause mortality by FABP-4 levels measured in baseline blood samples from 1371 incident CRC cases from the European Prospective Investigation into Cancer and Nutrition cohort. Competing risk analyses were adapted for CRC and non-CRC deaths.
View Article and Find Full Text PDF